Kidney abnormalities in young people living with HIV on dolutegravir-based regimens in Kampala, Uganda. [PDF]
Nasuuna EM +4 more
europepmc +1 more source
Brief Report: To Err Is Human, to Persist Is Diabolical: Are We Repeating the Same Cost and Insurance Coverage Mistakes Again With Injectable PrEP? [PDF]
D'Angelo AB +3 more
europepmc +1 more source
Pharmaco-economic profile, effectiveness, and safety of a dolutegravir based first line ART regimen among people living with HIV in South Gujarat. [PDF]
Sojitra B +8 more
europepmc +1 more source
SuperBola Cationic Biocides with an Extended Bolaamphiphilic Structure: How Much Is Too Much? [PDF]
Muldagaliyeva AY +4 more
europepmc +1 more source
Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment. [PDF]
Beca LSDAB +17 more
europepmc +1 more source
Incidence and management of pyrexia syndrome in patients treated with dabrafenib and trametinib: a retrospective study. [PDF]
Komisarof J +3 more
europepmc +1 more source
Apixaban Overdose with Massive Bleeding and Anti-Xa Levels. [PDF]
Kusko R +3 more
europepmc +1 more source
[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation]. [PDF]
Gámiz Rejano A +2 more
europepmc +1 more source
Management of an inferior vena cava thrombus with comorbid intracranial haemorrhage and cerebral amyloid angiopathy. [PDF]
MacKay K, Dinh CA, Dugani SB.
europepmc +1 more source
Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases. [PDF]
Fudaba H +9 more
europepmc +1 more source

